论文信息 - A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229). - 字舞流文

A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229).

K. Gelmon | L. Seymour | M. Tsao | D. Tu | S. Chia | P. Bedard | E. Amir | M. Cabanero | J. Hilton | D. Villa | R. Goodwin